Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Luisa Gutierrez M; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Josef Maria Bauer D; Benjamin Mauz J; Casanova-Cabral M; Gschwantler M; Paolo Russo F; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M, 2024. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure. J Hepatol.
Dominik N; Scheiner B; Zanetto A; Balcar L; Semmler G; Campello E; Schwarz M; Paternostro R; Simbrunner B; Hofer BS; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Simioni P; Reiberger T; Mandorfer M, 2024. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease. Aliment Pharmacol Ther.
Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B, 2024. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. J Hepatol.
Semmler G; Hartl L; Mendoza YP; Simbrunner B; Jachs M; Balcar L; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Szymanski R; Meyer EL; Scheiner B; Quehenberger P; Trauner M; Aigner E; Berzigotti A; Reiberger T; Mandorfer M, 2024. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify risk of clinically significant portal hypertension. Hepatology.
Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M, 2024. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient. J Hepatol.
Pfisterer N; Schwarz M; Madl C; Mandorfer M; Reiberger T, 2024. Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors' reply. Hepatol Int 18(2):706-707
Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Dannenberg V; Trauner M; Mandorfer M; Reiberger T, 2024. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality. JHEP Rep 6(1):100954
Schwarz C; Bauer D; Dorn L; Jachs M; Hartl L; Chromy D; Weseslindtner L; Pfisterer N; Hennlich B; Stückler A; Strassl R; Voill-Glaninger A; Hübl W; Willheim M; Köhrer K; Jansen-Skoupy S; Tomez S; Krugluger W; Madl C; Schwarz M; Balcar L; Semmler G; Brinkmann L; Burghart L; Antonitsch L; Weidinger G; Riedl F; Laferl H; Kurteva V; Traugott M; Hind J; Wenisch C; Aburaia A; Sebesta C; Schmid D; Rothweiler S; Remetic J; Gschwantler M; Maieron A; Reiberger T, 2023. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria. Wien Klin Wochenschr.
Schwarz C; Schubert R; Schwarz M; Schütz A; Jenke A; Bauer D; Steinwender B; Gutic E; Reiberger T; Haltmayer H; Gschwantler M, 2023. CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers. J Virus Erad 9(3):100338
Schwarz M; Schwarz C; Burghart L; Pfisterer N; Bauer D; Hübl W; Mandorfer M; Gschwantler M; Reiberger T, 2023. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes. PLoS One 18(8):e0290352
Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2023. An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis. JHEP Rep 5(8):100789
Jachs M; Panzer M; Hartl L; Schwarz M; Balcar L; Camp JV; Munda P; Mandorfer M; Trauner M; Aberle SW; Zoller H; Reiberger T; Ferenci P, 2023. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression. JHEP Rep 5(8):100751
Schwarz C; Schwarz M; Schmidbauer V; Kainberger F; Milos RI; Langenberger H; Gessl I; Funk G; Gschwantler M, 2023. Diffuse idiopathic skeletal hyperostosis as a cause for dysphagia in a patient with ankylosing spondylitis. Wien Klin Wochenschr 135(11-12):311-315
Pfisterer N; Schwarz M; Jachs M; Putre F; Ritt L; Mandorfer M; Madl C; Trauner M; Reiberger T, 2023. Endoscopic band ligation is safe despite low platelet count and high INR. Hepatol Int 17(5):1205-1214
Schwarz M; Schwarz C; Schütz A; Schwanke C; Krabb E; Schubert R; Liebich ST; Bauer D; Burghart L; Brinkmann L; Gutic E; Reiberger T; Haltmayer H; Gschwantler M, 2023. Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy. J Virus Erad 9(1):100319
Schwarz C; Chromy D; Bauer D; Duong N; Schmidbauer VU; Schwarz M; Mandorfer M; Rieger A; Trauner M; Gschwantler M; Reiberger T, 2023. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up. Wien Klin Wochenschr 135(15-16):420-428
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2023. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis. Clin Gastroenterol Hepatol 21(9):2318-2326.e7
Schwarz M; Schwarz C; Mossig E; Lampichler K; Schmidbauer V; Hofmann A; Langenberger H; Lagler H; Auer H; Gschwantler M, 2022. Isolated peritoneal involvement as a primary manifestation of cystic echinococcosis. Lancet Infect Dis 22(12):1769
Hartl L; Jachs M; Bauer D; Simbrunner B; Chromy D; Binter T; Steininger L; Schwarz C; Schwarz M; Burghart L; Strassl R; Trauner M; Gschwantler M; Mandorfer M; Reiberger T, 2022. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic. J Viral Hepat 29(12):1062-1072
Schwarz C; Chromy D; Bangert C; Schwarz M; Jachs M; Reiberger T; Gschwantler M, 2022. Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis. J Hepatol 77(1):254-255
Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodríguez-Tajes S; Genescà J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2022. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease. J Hepatol 76(4):812-821
Schmidbauer C; Chromy D; Schmidbauer VU; Schwarz M; Jachs M; Bauer DJM; Binter T; Apata M; Nguyen DT; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Breuer M; Strassl R; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T, 2021. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients. Liver Int 41(11):2622-2634
Schmidbauer C; Schwarz M; Schütz A; Schubert R; Schwanke C; Gutic E; Pirker R; Lang T; Reiberger T; Haltmayer H; Gschwantler M, 2021. Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy. PLoS One 16(6):e0252274
Publication list retrieved from NCBI using ImpactPubs
.